Tokyo, May 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061349) titled 'Analysis of Campylobacter glycan-recognizing antibodies related to Guillain-Barre syndrome in human serum' on May 1.
Study Type:
Observational
Primary Sponsor:
Institute - Chiba University
Condition:
Condition - Guillain-Barre syndrome
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To characterize antibodies against Campylobacter lipooligosaccharide(LOS) and gangliosides in human serum, and to determine the types and titers of antibodies associated with the development of Guillain-Barre syndrome.
Basic objectives2 - Bio-equivalence
Eligibility:
Age-lower limit - 1...